These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9728529)

  • 21. Role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for development of disease and should PCR be used to guide antiviral therapy?
    Abecassis MM; Koffron AJ; Buckingham M; Kaufman DB; Fryer JP; Stuart J; Stuart FP
    Transplant Proc; 1997; 29(1-2):800-1. PubMed ID: 9123532
    [No Abstract]   [Full Text] [Related]  

  • 22. [Polymerase chain reaction in diagnosis of cytomegalovirus infection in patients with organ allotransplants].
    Vediakov AM; Dolgikh MS
    Ter Arkh; 1998; 70(4):45-8. PubMed ID: 9612903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
    Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
    Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients.
    Boivin G; Quirk MR; Kringstad BA; Germain M; Jordan MC
    Antimicrob Agents Chemother; 1997 Apr; 41(4):860-2. PubMed ID: 9087507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preemptive therapy for the prevention of cytomegalovirus disease in renal transplant recipients: our preliminary experience.
    Paudice N; Mehmetaj A; Zanazzi M; Moscarelli L; Piperno R; Di Maria L; Bertoni E; Salvadori M
    Transplant Proc; 2009 May; 41(4):1204-6. PubMed ID: 19460517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
    Murray BM; Subramaniam S
    Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cytomegalovirus infection after renal transplantation: experience from a single center in China.
    Li Y; Yan H; Xue WJ; Tian PX; Ding XM; Pan XM; Feng XS; Xiang HL; Hou J; Tian XH; Zheng J; Ding CG; Fan P; Liu HB
    Ann Transplant; 2013 Mar; 18():125-35. PubMed ID: 23792512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine.
    Hasannia T; Moosavi Movahed SM; Vakili R; Rafatpanah H; Hekmat R; Valizadeh N; Rezaee SA
    Ren Fail; 2016 Oct; 38(9):1418-1424. PubMed ID: 27484706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipients.
    Lautenschlager I; Loginov R; Mäkisalo H; Höckerstedt K
    J Clin Virol; 2013 May; 57(1):50-3. PubMed ID: 23403239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients.
    Razonable RR; Åsberg A; Rollag H; Duncan J; Boisvert D; Yao JD; Caliendo AM; Humar A; Do TD
    Clin Infect Dis; 2013 Jun; 56(11):1546-53. PubMed ID: 23418272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis.
    Michaelides A; Liolios L; Glare EM; Spelman DW; Bailey MJ; Walters EH; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2001 Jul; 72(1):141-7. PubMed ID: 11468549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.
    Tong CY; Cuevas L; Williams H; Bakran A
    J Clin Microbiol; 1998 Sep; 36(9):2681-5. PubMed ID: 9705413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
    Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
    Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
    Einsele H; Hebart H; Kauffmann-Schneider C; Sinzger C; Jahn G; Bader P; Klingebiel T; Dietz K; Löffler J; Bokemeyer C; Müller CA; Kanz L
    Bone Marrow Transplant; 2000 Apr; 25(7):757-63. PubMed ID: 10745262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of cytomegalovirus infection after renal transplantation.
    Guandelin M; Xiuwu H; Juzhong G; Juanjun X; Zhiyou H
    Transplant Proc; 2000 Nov; 32(7):1930-1. PubMed ID: 11120006
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection--a single centre experience].
    Vejražková E; Hubáček P; Kutová R; Plíšková L; Košťál M; Štěpánová V; Zavřelová A; Radocha J; Malá E; Žák P
    Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):160-8. PubMed ID: 26448304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.
    Len O; Gavaldà J; Aguado JM; Borrell N; Cervera C; Cisneros JM; Cuervas-Mons V; Gurguí M; Martin-Dávila P; Montejo M; Muñoz P; Bou G; Carratalà J; Torre-Cisneros J; Pahissa A;
    Clin Infect Dis; 2008 Jan; 46(1):20-7. PubMed ID: 18171208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection.
    Bitsch A; Kirchner H; Dennin R; Hoyer J; Fricke L; Steinhoff J; Sack K; Bein G
    Transplantation; 1993 Jul; 56(1):108-13. PubMed ID: 8392761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.